Why Is This Treatment Important?
The effectiveness of antithrombotic agents in reducing stroke mortality, morbidity and recurrence rates has been studied in several large clinical trials. While the use of these agents for patients with acute ischemic stroke and transient ischemic attacks continues to be the subject of study, substantial evidence is available from completed studies. Data at this time suggest that antithrombotic therapy should be administered within 2 days of symptom onset in acute ischemic stroke patients to reduce stroke mortality and morbidity as long as no contraindications exist.
What the Scores Mean
A higher percentage is good because it means more patients received the recommended treatment. However, a lower score does not necessarily indicate poor care. You should consider the overall quality of a facility in addition to individual category scores.
About the Data
The data on this site represent the time period of October 2012 through September 2013 and are the most recent available. They are reported to the Joint Commission as a core measure set in conjunction with the Get with the Guidelines program of the American Heart Association and American Stroke Association. For more information, please visit the Joint Commission website and the American Heart Association and American Stroke Association Get with the Guidelines website.